Related references
Note: Only part of the references are listed.Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Imaging Active Urokinase Plasminogen Activator in Prostate Cancer
Aaron M. LeBeau et al.
CANCER RESEARCH (2015)
Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression
Jiyoon Lee et al.
CLINICAL CANCER RESEARCH (2015)
Stromal biology and therapy in pancreatic cancer: a changing paradigm
Albrecht Neesse et al.
GUT (2015)
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
Ignacio Garrido-Laguna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations
Ozgun Babur et al.
GENOME BIOLOGY (2015)
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives
Robert F. Shearer et al.
GENES TO CELLS (2015)
SerpinB2 (PAI-2) Modulates Proteostasis via Binding Misfolded Proteins and Promotion of Cytoprotective Inclusion Formation
Jodi A. Lee et al.
PLOS ONE (2015)
Pancreatic Cancer Stroma: Friend or Foe?
Jesse Gore et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment
David Herrmann et al.
CARCINOGENESIS (2014)
The Molecular Signature of the Stroma Response in Prostate Cancer-Induced Osteoblastic Bone Metastasis Highlights Expansion of Hematopoietic and Prostate Epithelial Stem Cell Niches
Berna C. Oezdemir et al.
PLOS ONE (2014)
Stromal response to Hedgehog signaling restrains pancreatic cancer progression
John J. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
Michael J. Duffy et al.
BREAST CANCER RESEARCH (2014)
Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer
Max Nobis et al.
CANCER RESEARCH (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Stromal biology and therapy in pancreatic cancer
Albrecht Neesse et al.
GUT (2011)
Dependence on Endocytic Receptor Binding via a Minimal Binding Motif Underlies the Differential Prognostic Profiles of SerpinE1 and SerpinB2 in Cancer
Blake J. Cochran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Pancreatic Cancer: Pathobiology, Treatment Options, and Drug Delivery
Jing Li et al.
AAPS JOURNAL (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Scoring of collagen organization in healthy and diseased human dermis by multiphoton microscopy
Riccardo Cicchi et al.
JOURNAL OF BIOPHOTONICS (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
SerpinB2 deficiency modulates Th1/Th2 responses after schistosome infection
W. A. Schroder et al.
PARASITE IMMUNOLOGY (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Novel Organotypic Model Mimics the Tumor Microenvironment
Sini Nurmenniemi et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity
Blake J. Cochran et al.
BMC BIOTECHNOLOGY (2009)
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Salvatore Ulisse et al.
CURRENT CANCER DRUG TARGETS (2009)
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses
Zachary S. Boyd et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma
Aiqun Xue et al.
PANCREAS (2008)
Revisiting the biological roles of PAI2 (SERPINB2) in cancer
David R. Croucher et al.
NATURE REVIEWS CANCER (2008)
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells
Cedric Gaggioli et al.
NATURE CELL BIOLOGY (2007)
A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells
David R. Croucher et al.
BIOCHEMICAL JOURNAL (2007)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma
Ross Smith et al.
WORLD JOURNAL OF SURGERY (2007)
Preclinical evaluation of Bi-213-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma
Tarnantha K. Stutchbury et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Daruka Mahadevan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The urokinase/PAI-2 complex - A new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein
D Croucher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Development of a quantitative method to analyse tumour cell invasion in organotypic culture
ML Nyström et al.
JOURNAL OF PATHOLOGY (2005)
Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines
F Al-Ejeh et al.
EXPERIMENTAL CELL RESEARCH (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Intravital imaging of cell movement in tumours
J Condeelis et al.
NATURE REVIEWS CANCER (2003)
Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma
AR Shekouh et al.
PROTEOMICS (2003)
Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression
SC Barry et al.
HUMAN GENE THERAPY (2001)
Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma
H Shiomi et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
